
Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
The Way to Fruitful Weight reduction: Individual Wellbeing Excursions - 2
Birds at a college changed beak shapes during the pandemic. It might be a case of rapid evolution - 3
Merz: 80% of Syrians in Germany should return in three years - 4
Germany unveils rescue plan for struggling chemical sector - 5
Minnesota jury says Johnson & Johnson owes $65.5 million to woman with cancer who used talcum powder
Vote In favor of Your Favored Menial helper Administration
Step by step instructions to Think about Disc Rates Across Various Banks
The Appearance of Experience: Embracing the Reduced Portage Horse
Soldiers seize power in Guinea-Bissau and detain the president
Everyone knows F1 is for the girls. I wandered into the Las Vegas desert to find out why.
Thousands of genomes reveal the wild wolf genes in most dogs’ DNA
In wrangling dark matter, some scientists find inspiration in the Torah, Krishna and Christ
The Fate of Mechanical technology: 5 Headways Forming Tomorrow
'Sex and the City' star Kim Cattrall marries longtime partner Russell Thomas in intimate London wedding












